NousCom receives $49M to trial off-the-shelf cancer vaccine
Cancer vaccine startup NousCom has raised €42 million ($49…
Juno and AstraZeneca pair two hot immunotherapies in new cancer study
Juno Therapeutics ($JUNO) and AstraZeneca ($AZN) are joining…